Volume 51, Issue 6, Pages (September 2013)

Slides:



Advertisements
Similar presentations
Volume 43, Issue 1, Pages (July 2011)
Advertisements

Volume 21, Issue 5, Pages (November 2011)
The ER-Mitochondria Tethering Complex VAPB-PTPIP51 Regulates Autophagy
Volume 36, Issue 5, Pages (December 2009)
Volume 53, Issue 4, Pages (February 2014)
Volume 33, Issue 2, Pages (January 2009)
Lisa J Corcoran, Timothy J Mitchison, Qing Liu  Current Biology 
Volume 22, Issue 3, Pages (May 2006)
Volume 57, Issue 3, Pages (February 2015)
Volume 54, Issue 1, Pages (April 2014)
Volume 44, Issue 4, Pages (November 2011)
Yu-Hsin Chiu, Jennifer Y. Lee, Lewis C. Cantley  Molecular Cell 
Volume 22, Issue 5, Pages (May 2012)
Richard C. Centore, Stephanie A. Yazinski, Alice Tse, Lee Zou 
Volume 65, Issue 5, Pages e5 (March 2017)
Monica C. Rodrigo-Brenni, Erik Gutierrez, Ramanujan S. Hegde 
Volume 15, Issue 22, Pages (November 2005)
Oliver I. Fregoso, Shipra Das, Martin Akerman, Adrian R. Krainer 
Volume 60, Issue 1, Pages 7-20 (October 2015)
Volume 45, Issue 5, Pages (March 2012)
Volume 27, Issue 1, Pages (July 2007)
Volume 55, Issue 1, Pages (July 2014)
Volume 52, Issue 6, Pages (December 2013)
Volume 67, Issue 6, Pages e7 (September 2017)
Distinct Autophagosomal-Lysosomal Fusion Mechanism Revealed by Thapsigargin- Induced Autophagy Arrest  Ian G. Ganley, Pui-Mun Wong, Noor Gammoh, Xuejun.
Volume 15, Issue 2, Pages (August 2008)
MAGE-RING Protein Complexes Comprise a Family of E3 Ubiquitin Ligases
Volume 20, Issue 4, Pages (April 2004)
Jungmook Lyu, Vicky Yamamoto, Wange Lu  Developmental Cell 
Volume 16, Issue 2, Pages (February 2009)
Volume 115, Issue 6, Pages (December 2003)
Volume 24, Issue 1, Pages (January 2013)
Volume 24, Issue 12, Pages e4 (September 2018)
SGK3 Mediates INPP4B-Dependent PI3K Signaling in Breast Cancer
Volume 66, Issue 4, Pages e5 (May 2017)
HDAC5, a Key Component in Temporal Regulation of p53-Mediated Transactivation in Response to Genotoxic Stress  Nirmalya Sen, Rajni Kumari, Manika Indrajit.
Volume 55, Issue 1, Pages (July 2014)
Oncogenic Ras-Induced Expression of Noxa and Beclin-1 Promotes Autophagic Cell Death and Limits Clonogenic Survival  Mohamed Elgendy, Clare Sheridan,
Septins Regulate Actin Organization and Cell-Cycle Arrest through Nuclear Accumulation of NCK Mediated by SOCS7  Brandon E. Kremer, Laura A. Adang, Ian.
Lizhong Xu, Veronica Lubkov, Laura J. Taylor, Dafna Bar-Sagi 
The Actin-Bundling Protein Palladin Is an Akt1-Specific Substrate that Regulates Breast Cancer Cell Migration  Y. Rebecca Chin, Alex Toker  Molecular.
A Critical Role for Noncoding 5S rRNA in Regulating Mdmx Stability
Volume 24, Issue 4, Pages e5 (April 2017)
Volume 20, Issue 4, Pages (November 2005)
Yi Tang, Jianyuan Luo, Wenzhu Zhang, Wei Gu  Molecular Cell 
Volume 19, Issue 6, Pages (September 2005)
Extracellular Regulated Kinase Phosphorylates Mitofusin 1 to Control Mitochondrial Morphology and Apoptosis  Aswin Pyakurel, Claudia Savoia, Daniel Hess,
Volume 10, Issue 4, Pages (February 2015)
Sara K. Donnelly, Ina Weisswange, Markus Zettl, Michael Way 
Virus-Induced Abl and Fyn Kinase Signals Permit Coxsackievirus Entry through Epithelial Tight Junctions  Carolyn B. Coyne, Jeffrey M. Bergelson  Cell 
The ISG15 Conjugation System Broadly Targets Newly Synthesized Proteins: Implications for the Antiviral Function of ISG15  Larissa A. Durfee, Nancy Lyon,
Volume 50, Issue 6, Pages (June 2013)
Richard W. Deibler, Marc W. Kirschner  Molecular Cell 
ASPP2 Regulates Epithelial Cell Polarity through the PAR Complex
Volume 25, Issue 5, Pages (March 2007)
Volume 52, Issue 2, Pages (October 2013)
Volume 57, Issue 6, Pages (March 2015)
The ISG15 Conjugation System Broadly Targets Newly Synthesized Proteins: Implications for the Antiviral Function of ISG15  Larissa A. Durfee, Nancy Lyon,
Centrosome-Associated NDR Kinase Regulates Centrosome Duplication
Volume 125, Issue 4, Pages (May 2006)
Volume 5, Issue 6, Pages (December 2013)
Volume 36, Issue 1, Pages (October 2009)
Volume 27, Issue 6, Pages e4 (May 2019)
Oliver I. Fregoso, Shipra Das, Martin Akerman, Adrian R. Krainer 
Volume 134, Issue 1, Pages (July 2008)
A Direct HDAC4-MAP Kinase Crosstalk Activates Muscle Atrophy Program
Volume 22, Issue 3, Pages (May 2006)
Volume 33, Issue 5, Pages (March 2009)
Fig. 5 C9orf72 knockdown disrupts autophagy induction.
Volume 33, Issue 3, Pages (May 2015)
Presentation transcript:

Volume 51, Issue 6, Pages 819-828 (September 2013) Proteasomes Activate Aggresome Disassembly and Clearance by Producing Unanchored Ubiquitin Chains  Rui Hao, Priyaanka Nanduri, Yanhua Rao, R. Scott Panichelli, Akihiro Ito, Minoru Yoshida, Tso-Pang Yao  Molecular Cell  Volume 51, Issue 6, Pages 819-828 (September 2013) DOI: 10.1016/j.molcel.2013.08.016 Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 1 HDAC6 Is Required for Aggresome Deaggregation and Clearance A549 cells were treated with MG132 (5 μM) for 24 hr to induce aggresome formation followed by MG132-free medium for the indicated times. Aggresomes were identified by staining with an antibody against ubiquitin (ub, clone FK1). (A) Ubiquitin immunostaining (red) indicates that the large aggresomes (0 hr) were deaggregated (12 hr) before final clearance (24 hr). Bottom, zoomed areas (white squares). Nuclei were stained with DAPI (blue). The status of aggresomes at different time points after MG132 washout was quantified in the histogram. (B) Representative images of HDAC6 (green) in relationship to the aggresome (red) by double immunostaining during MG132 washout. Bottom, zoomed areas (white squares). Note that protein aggregates are no longer positive for HDAC6 after 12 hr washout (middle). (C) A549 cells were treated with an HDAC6-selective inhibitor, Tubastatin A (TBSA, 10 μM), pan-HDAC inhibitor, Trichostatin A (TSA, 1 μM), or class I HDAC inhibitors, MS275 (10 μM), or sodium butyrate (NaBut, 1 mM) during MG132 washout. The presence of aggresome was analyzed and quantified as described in (A). (D) Representative images of HDAC6 and the aggresome (ub) in TBSA-treated cells. For (A) and (C), three independent experiments were quantified. Error bars show ± SEM. The scale bar represents 25 μm. See also Figure S1. Molecular Cell 2013 51, 819-828DOI: (10.1016/j.molcel.2013.08.016) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 2 Poh1 Facilitates Aggresome Clearance by Producing Unanchored Ubiquitin Chains (A) Immunopurified FLAG-HDAC6 produced in HEK 293T cells was incubated with unanchored ubiquitin chains (K63-linked Ub 1-7) or ubiquitinated protein (ub-protein, see the Experimental Procedures for details). The input and bound fractions were analyzed by immunoblotting with the indicated antibodies. (B) A549 cells were transfected with control or Poh1-specific siRNA and treated with MG132 (5 μM, 24 hr) in order to induce aggresome or followed by MG132 washout as indicated. Aggresomes (marked by arrows) were detected and quantified as described in Figure 1A. Values represent the mean ± SEM (n = 3). (C) Poh1 knockdown (KD) cells were treated with MG132 to induce aggresomes, and MG132 washout was performed in the presence of DMSO or 2.5 μM of nocodazole (Noc.) for 24 hr. Cells containing aggresomes were quantified and averaged from three independent experiments in the histogram. Note that nocodazole treatment disrupted microtubule networks (α-tubulin, green) but had no effect on aggresome clearance. (D) A549 cells stably expressing shRNA-resistant wild-type (WT) or catalytically inactive (CI) H113/115A mutant Poh1 were infected with Poh1-shRNA lentivirus. The percentage of cells containing an aggresome after MG132 washout was analyzed and quantified as described in (B). (E) Poh1 KD cells were pretreated with MG132 to induce aggresome formation. Cells were microinjected with indicated ubiquitin species or BSA mixed with fluorescence-conjugated dextran 3 hr after MG132 was removed. The presence of aggresomes was analyzed 21 hr postinjection. Injected cells were identified by dextran (green, top) and marked by white dotted lines (bottom). Aggresomes were identified by staining with an antibody specific for K48-linked ubiquitin (red, clone Apu2) and marked by white arrowheads in injected cells. Note that only Poh1 KD cells injected with the K63-linked ubiquitin chains do not contain aggresomes. Noninjected cells retained aggresomes under all conditions (yellow arrowheads) and served as an internal control. Right, the quantification from three independent experiments. In each experiment, 50 to 100 injected cells were scored. p value is indicated in the figure. Error bars indicate ± SEM. (F) Control and Poh1 KD A549 cells were treated with 5 μM MG132 for 24 hr or with MG132 followed by 24 hr washout in the presence or absence of 10 mM 3-MA, as indicated. Detergent-insoluble fractions were isolated from whole-cell lysates and resolved by SDS-PAGE followed by immunoblotting with a K48- or K63-specific ubiquitin antibodies, as indicated. Actin was used as a loading control. See also Figures S2, S3, S4, and S8. Molecular Cell 2013 51, 819-828DOI: (10.1016/j.molcel.2013.08.016) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 3 HDAC6 Binds Unanchored Ubiquitin Chains during Aggresome Clearance in a Poh1-Dependent Manner (A) Representative image of HDAC6 and aggresome (ub) in Poh1 KD cells 24 hr after MG132 washout. (B) FLAG-HDAC6 was immunoprecipitated under the following conditions: (1) no treatment, (2) 5 μM MG132 for 24 hr, (3) 12 hr MG132 washout, and (4) 24 hr MG132 washout. The immune complexes were subjected to heating, and the eluates were treated with isopeptidase T (IsoT) as indicated (see the Experimental Procedures for details). Samples were analyzed by immunoblotting with antibodies for ubiquitin or HDAC6. Note that MG132 washout (condition 2 versus 3) led to a decrease in total ubiquitinated protein levels in whole-cell lysate (WCL) but an increase in HDAC6-associated free ubiquitin chains. (C) Free ubiquitin chains associated with HDAC6 in WT and Poh1 KD cells were assessed 12 hr after MG132 washout. Note that Poh1 KD led to the accumulation of total ubiquitinated proteins (left) but a reduction of HDAC6-associated unanchored ubiquitin chains (right). (D) Free ubiquitin chains released from HDAC6-IP components were sequentially immunoblotted with a pan-ubiquitin antibody (pan-ub), K63-specific ubiquitin antibody (K63-ub), and K48-specific ubiquitin antibody (K48-ub). Recombinant K63- or K48-linked polyubiquitin chains were loaded onto the same gel in order to validate the specificity of linkage-specific ubiquitin antibodies. See also Figure S5. Molecular Cell 2013 51, 819-828DOI: (10.1016/j.molcel.2013.08.016) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 4 Free Ubiquitin Chains Regulate HDAC6 Activity (A) Immunopurified FLAG-HDAC6 WT, H215A/H610A CI, and various point mutants were incubated with free ubiquitin chains as indicated. The bound fractions were detected by immunoblotting with an ubiquitin antibody. (B) Top, filter-trap analysis of SDS-insoluble ubiquitinated aggregates accumulated in WT, HDAC6 KO, and KO MEFs stably expressing human WT HDAC6 or W1182A mutant subject to 24 hr MG132 washout. The relative ubiquitin signal intensity was quantified and is presented in parenthesis under each genotype where HDAC6 KO MEFs was set at 100. Bottom, whole-cell extracts from indicated cell lines were immunoblotted with antibodies for human HDAC6 (hHDAC6), mouse HDAC6 (mHDAC6), and actin. (C) Cortactin, the acetyltransferase CBP, and WT or HDAC6 mutant plasmids were cotransfected into HEK 293T cells as indicated. Cortactin was immunoprecipitated and immunoblotted with an antibody for acetylated (Ac) cortactin or total cortactin. The relative cortactin-acetylation level (Ac-cortactin/cortactin) was quantified by scanning densitometry and is presented in the right panel. Error bars indicate ± SD (n = 3). The statistical significance was assessed with two-way ANOVA analysis with Dunnett’s test. ∗p < 0.05. See also Figure S6. Molecular Cell 2013 51, 819-828DOI: (10.1016/j.molcel.2013.08.016) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 5 Deaggregation of the Aggresome Requires the Actinomyosin System A549 cells were pretreated with MG132 (5 μM) for 24 hr to induce aggresome formation. (A) Representative images of the aggresome (ubiquitin, green) and F-actin (red, Rhodamine-Phalloidin) 12 hr after MG132 washout in cells with indicated treatment. In the panels of F-actin, the location of the aggresome is marked by an arrowhead. Right, cells exhibiting F-actin punctae around the aggresome were quantified from three experiments. Error bars indicate ± SEM. ∗p < 0.01. (B) Representative staining of F-actin and a deaggregated aggresome 12 hr after MG132 washout. Right, the zoomed areas (white squares). (C) A549 cells transfected with the indicated siRNA were imaged 0 or 24 hr after MG132 washout. Aggresomes (arrows) were detected with an antibody against ubiquitin (red), and the percentage of cells retained an aggresome was quantified from three independent experiments. Error bars show ± SEM. (D) Costaining of HDAC6 (green) and ubiquitin (red) in cells expressing indicated siRNA 24 hr after MG132 washout. Arrows mark aggresomes. Right, the quantification of aggresomes that are positive for HDAC6 (n = 3). Error bars show ± SEM. ∗p < 0.01. See also Figure S7. Molecular Cell 2013 51, 819-828DOI: (10.1016/j.molcel.2013.08.016) Copyright © 2013 Elsevier Inc. Terms and Conditions